SHARE Cancer Support

Learn about Clinical Trial DV-006, a study exploring disitamab vedotin (DV) for people diagnosed with HER2-positive, HER2-low, or HER2-ultralow, advanced or metastatic breast cancer.

DV is a targeted therapy designed to deliver treatment directly to cancer cells. This Phase1b/2 trial is evaluating safety, side effects, dosage and early signs of effectiveness.

This trial is shared for educational purposes only and may not be the right option for you; we encourage you to explore other clinical trials and discuss all possible options with your doctor.

Stay informed about ongoing clinical trials. For more on DV-OO6, check out all the posts in the series. Learn more at: https://bit.ly/3Q1uS6l

Uterine cancer is on the rise — but awareness is rising, too.

This June, SHARE is proud to partner with and for , a global campaign for Uterine Cancer Awareness Month.

Abnormal bleeding — especially after menopause — is one of the most common warning signs of uterine cancer. Other symptoms, like pelvic pain or changes in your body, should not be dismissed as “just menopause” or “normal aging.”

We’re jumping to help break the silence around gynecologic health, support people affected by uterine/endometrial cancer, and encourage everyone to listen to their bodies and seek care when something feels different.

Join the movement: igcs.org/jump4june

Learn about Clinical Trial DV-006, a study exploring disitamab vedotin (DV) for people diagnosed with HER2-positive, HER2-low, or HER2-ultralow, advanced or metastatic breast cancer.

DV is a targeted therapy designed to deliver treatment directly to cancer cells. This Phase1b/2 trial is evaluating safety, side effects, dosage and early signs of effectiveness.

This trial is shared for educational purposes only and may not be the right option for you; we encourage you to explore other clinical trials and discuss all possible options with your doctor.

Stay informed about ongoing clinical trials. For more on DV-OO6, check out all the posts in the series. Learn more at https://bit.ly/3Q1uS6l

Learn about Clinical Trial DV-006, a study exploring disitamab vedotin (DV) for people diagnosed with HER2-positive, HER2-low, or HER2-ultralow, advanced or metastatic breast cancer.

DV is a targeted therapy designed to deliver treatment directly to cancer cells. This Phase1b/2 trial is evaluating safety, side effects, dosage and early signs of effectiveness.

This trial is shared for educational purposes only and may not be the right option for you; we encourage you to explore other clinical trials and discuss all possible options with your doctor.

Stay informed about ongoing clinical trials. For more on DV-OO6, check out all the posts in the series. Learn more at the link in bio.

Mother’s Day can bring joy, gratitude, grief, longing, love, and everything in between. 💜

Today, we’re honoring and holding space for every experience.

To the mothers navigating cancer, survivors grieving fertility loss, caregivers who mother others, those longing to become mothers, those missing their mom today, and anyone finding today complicated or heavy, we see you.

However today finds you, you are not alone. 💐

Today is World Ovarian Cancer Day 💙

Ovarian cancer symptoms are often subtle and easy to dismiss, which is why awareness and education matter so much. Persistent bloating, pelvic pain, feeling full quickly, and changes in urination are symptoms that deserve attention.

Today we honor every patient, survivor, caregiver, advocate, and loved one impacted by ovarian cancer while continuing to push for awareness, earlier detection, research, and support.

Diagnosed at 24 with stage 3 breast cancer—after thinking it was just a pulled muscle.
In this episode, Aastha Saggar ()shares what it’s really like to face cancer so young: the confusion of early appointments, learning a whole new medical language overnight, and navigating chemo, a double mastectomy, radiation, and chemo-induced menopause.

But what stays with you most is her mindset—taking it brick by brick. Staying present. Finding gratitude in the middle of it all.
Her story is raw, honest, and deeply grounding.

Listen now and hear how vulnerability, resilience, and community carried her through—and how she’s now helping others do the same.
Listen wherever you get your podcasts

Asian American and Pacific Islander Heritage Month is a time to honor the strength, culture, and stories within AAPI communities.

In cancer care, those stories matter. Representation, access, and culturally responsive support can make all the difference.

This month and always, we stand with AAPI patients, survivors, caregivers, and families.

There’s something for everyone this week at SHARE 🤍

Whether you’re caring for someone you love, looking to stay informed on the latest in uterine cancer research, or just needing a space to feel seen and supported, we’re here for you.

✨ Tuesday: A special presentation on prioritizing your wellbeing as a caregiver
✨ Wednesday: What’s new in uterine cancer from SGO 2026
✨ Ongoing: Support groups all week long

You don’t have to navigate this alone. We hope to see you there 💛

🔗 Register + learn more at sharecancersupport.org